Ind-Swift Laboratories sets up new marketing office in New Delhi

23 Sep 2024 Evaluate

Ind-Swift Laboratories has set up a new state-of-the-art marketing office at The Great Eastern Centre, Nehru Place, New Delhi. This new marketing office is in line with its strategic objective to establish and strengthen its position in the formulations business both Ethical and Generics

This office will be the central hub for all operations related to its Ethical Pharmaceutical Business, encompassing critical functions such as Marketing, Business Development, HR, New Product Development, Admin, and Medical Affairs. Its goal is to create a cohesive and highly functional environment that aligns with its mission to recapture slot in India’s top pharmaceutical companies.

The Delhi office is specifically designed to lead and drive marketing efforts for its Ethical Pharma Business and manage field sales force. By investing in this infrastructure and expanding its operational capabilities, it is positioning its self to capture a larger market share in India’s burgeoning pharmaceutical sector.

Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).


Ind-Swift Lab. Share Price

107.30 1.35 (1.27%)
22-Jan-2026 10:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1636.90
Dr. Reddys Lab 1216.95
Cipla 1378.90
Zydus Lifesciences 885.85
Lupin 2181.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×